CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 884546
SAN FRANCISCO, CA
Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$92,468,664
+$2,780,452 QoQ
Shares Held
1,616,020
+1.8% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 561 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. BMRN ranks #20 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in BMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,468,664 | 1,616,020 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $89,688,212 | 1,587,683 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $84,611,204 | 1,423,712 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $75,694,016 | 1,397,600 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $85,539,751 | 1,556,117 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $93,567,180 | 1,423,508 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $98,520,432 | 1,401,628 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $110,810,334 | 1,345,929 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $117,150,452 | 1,341,315 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $132,953,248 | 1,378,897 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $115,448,438 | 1,304,797 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $110,188,049 | 1,271,205 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $122,428,271 | 1,259,032 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $128,532,510 | 1,241,980 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $102,996,991 | 1,215,017 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $99,618,855 | 1,202,110 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $86,971,113 | 1,128,030 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $97,267,960 | 1,100,939 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $81,263,015 | 1,051,404 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $51,425,740 | 616,320 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $43,904,081 | 581,434 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $60,877,028 | 694,230 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $51,919,806 | 682,437 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $76,768,666 | 622,415 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $50,415,319 | 596,631 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||